Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.1900 (4.2%) ($6.7500 - $7.2500) on Fri. Aug. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 44 | Latest Price | $7.1900(4.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(58%) IBB(58%) ARKK(56%) IWO(56%) | Factors Impacting TGTX price | TGTX will decline at least -1.985% in a week (0% probabilities). VIXM(-39%) VXX(-38%) TLT(-9%) IFRA(-7%) UUP(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
1 - 5 Day Possible Target | $-4.45(-161.89%) | Resistance Level | $7.34 | 5 Day Moving Average | $6.78(6.05%) | 10 Day Moving Average | $7.07(1.7%) | 20 Day Moving Average | $7.34(-2.04%) | To recent high | -20% | To recent low | 14.7% | Market Cap | $911m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |